Arizona Attorney General Kris Mayes says the pharmaceutical company GlaxoSmithKline manipulated patents to reduce ...

GlaxoSmithKline does not know when it will resume producing Excedrin. Pharmaceutical giant GlaxoSmithKline has temporarily stopped production of Excedrin, its popular over-the-counter migraine ...

Glaxosmithkline, with multiple operations in Montco, just scored a major regulatory win that could reshape how lupus ...

This morning, GlaxoSmithKline announced a $3 billion criminal settlement with the Department of Justice to settle accusations that it didn't tell regulators about safety problems with an infamous ...

GlaxoSmithKline said it would buy cancer-focused drug company Tesaro for about $4.16 billion, positioning the health-care giant in a promising, but fiercely competitive, area of medicine.

AnaptysBio’s lead drug rosnilimab showed promise in RA, but lack of a Phase 3 plan and limited pipeline raise concerns. Find ...

U.S. Senator Maggie Hassan said on Friday she is launching an investigation into British pharmaceutical giant GlaxoSmithKline ...

Democratic U.S. Senator Maggie Hassan said on Friday she is launching an investigation into British pharmaceutical giant GlaxoSmithKline's decision to discontinue a widely used asthma inhaler for ...

GlaxoSmithKline downgraded full-year earnings expectations, as its second-quarter profit was hit by currency moves, weak sales of its respiratory drugs and the continuing bribery investigation in ...

GlaxoSmithKline & other drugmakers delist FDA patents, after FTC 'Big Pharma' scrutiny. After the Federal Trade Commission sent warning letters to 10 drugmakers over 100 "improper" patents, 3 ...

GlaxoSmithKline officials on Thursday did not immediately respond to a request for comment. Until it was discontinued in 2023, Flovent was one of the most widely prescribed asthma medications in ...

GlaxoSmithKline PLC Leadership Team Success. GlaxoSmithKline PLC leaders and executives have shown their dedication by being a leading pharmaceutical company and research and development firm.